Key considerations based on pharmacokinetic/pharmacodynamic in the design of antibody-drug conjugates
BackgroundAntibody-drug conjugate (ADC) is an anticancer drug that links toxins to specifically targeted antibodies via linkers, offering the advantages of high target specificity and high cytotoxicity. However, complexity of its structural composition poses a greater difficulty for drug design stud...
Asıl Yazarlar: | , , , , , , , |
---|---|
Materyal Türü: | Makale |
Dil: | English |
Baskı/Yayın Bilgisi: |
Frontiers Media S.A.
2025-01-01
|
Seri Bilgileri: | Frontiers in Oncology |
Konular: | |
Online Erişim: | https://www.frontiersin.org/articles/10.3389/fonc.2024.1459368/full |